000250 — Sam Chun Dang Pharm Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩3tn
- KR₩3tn
- KR₩193bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 19,600 | 7,495 | -10,361 | 8,832 | -4,188 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 8,509 | 1,027 | 1,294 | 8,991 | 20,105 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3,997 | -11,958 | -5,380 | -12,194 | -920 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 30,603 | 3,250 | -7,707 | 13,279 | 23,428 |
Capital Expenditures | -10,159 | -11,798 | -29,307 | -46,546 | -21,973 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -9,181 | -7,409 | -744 | -7,392 | 13,552 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -19,340 | -19,206 | -30,050 | -53,938 | -8,421 |
Financing Cash Flow Items | -997 | -1,013 | 0 | — | -0.099 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2,415 | 14,662 | 27,691 | 13,325 | 3,387 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8,801 | -1,337 | -9,822 | -27,013 | 18,326 |